Covid-19. COVID-19 , virus identified
Conditions
Interventions
Intervention 1: Intervention group: This group receives 50 mg daily dose of sertraline with standard treatment including corticosteroids + anticoagulants + Remdesivir during hospitalization. Intervent
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients 18-65 years old with Covid-19 need to be hospitalized Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: Effective underlying diseases as a result of the study, whether previous cardiovascular or pulmonary diseases or other diseases and special conditions such as diabetes, weakened immune system and pregnancy History of psychiatric illness or previous use of SSRIs including Sertraline
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: Daily, during the hospitalization period. Method of measurement: Patient clinical information collection form.;Requires ICU care. Timepoint: Daily, during the hospitalization period. Method of measurement: Patient clinical information collection form.;Oxygen Saturation. Timepoint: Daily, during the hospitalization period. Method of measurement: Patient clinical information collection form.;Respiratory rate. Timepoint: Daily, during the hospitalization period. Method of measurement: Patient clinical information collection form.;Type of oxygen therapy. Timepoint: Daily, during the hospitalization period. Method of measurement: Patient clinical information collection form.;Death. Timepoint: Daily, during the hospitalization period. Method of measurement: Patient clinical information collection form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahla sadat Esmaeili
Sabzevar University of Medical Sciences
Outcome results
None listed